Stents succeed in heart attack pilot studies
This article was originally published in Clinica
Stenting reduces the risk of abrupt closure, it cuts target lesion revascularisation and reduces restenosis in elective patients. So why not use stents in acute myocardial infarction patients, Cindy Grines, a one-time fan of thrombolysis who is now a confirmed fan of primary angioplasty asked. Because of the thrombosis risk, answered her opponents. Not a problem, said Dr Grines, when she presented data from a number of pilot studies at the ACC meeting in Anaheim, California, last month.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.